CMSC 30th Annual Meeting in June to Examine Promising Advances in MS Research, Treatment
The Consortium of Multiple Sclerosis Centers (CMSC), a pre-eminent organization of multiple sclerosis (MS) healthcare providers, will hold its 30th…
Articles by Patricia Silva, PhD
European Regulatory Agency Finds Gilenya Not of Added Benefit to Certain RRMS Patients
A new assessment by a European regulatory agency failed to find fingolimod of added benefit to comparator therapies for people with highly active relapsing-remitting multiple sclerosis (RRMS)…
Can Playing Video Games Reduce MS-induced ‘Brain Fog’?
Video games targeting cognitive abilities may improve brain function in patients with multiple sclerosis (MS), a new study found. Results,…
#MySupportHero Program Celebrates MS Caregivers in All Walks of Life
To celebrate the many family, friends, healthcare professionals, and advocacy communities offering vital support to people living with multiple sclerosis (MS) day…
Damage to Nerve Synapses in MS Mouse Model Found to Be Unrelated to Myelin Destruction
Researchers found that nerve cell connections in the brain, called synapses, were damaged in a mouse model of multiple sclerosis (MS) through a…
MS Risk Linked to Mothers with Vitamin D Deficiency in First Trimester of Pregnancy
Children whose mothers were vitamin D deficient during the early stages of pregnancy are at an elevated risk for developing…
Kessler Foundation MS Researcher Awarded $70,000 Fellowship to Investigate Cognitive Function
Silvana L. Costa, PhD from the Kessler Foundation, was recently awarded a Switzer Research Fellowship by the National Institute on Disability, Independent…
New Study Explores Brain Damage in MS Patients with Autoimmune Comorbidities
People with multiple sclerosis (MS) who also suffer from other autoimmune conditions, like thyroid disease or diabetes, have more severe brain damage…
Science Foundation Awards to Further Work into Rehabilitative Robotics, Online Tools at Northwestern University
Two scientists at Northwestern University, Anne Marie Piper and Brenna Argall, recently received the Faculty Early Career Development (CAREER) Award from…
In ‘Take Action on MS,’ a New Web Series, Actress Madeleine Stowe Tackles Topics of Import to RRMS Patients
Genzyme, a specialty care unit of Sanofi, announced that TV and film actress Madeleine Stowe will host its new online series, “…
National MS Society Names Children’s Health of North Texas a Comprehensive MS Care Center
Children’s Health of North Texas has been designated a Center for Comprehensive MS Care by the National Multiple Sclerosis Society, making it…
MSAA Draws Attention to Specific Multiple Sclerosis Symptoms Each Week of March, MS Awareness Month
March is Multiple Sclerosis (MS) Awareness Month, and the Multiple Sclerosis Association of America (MSAA) will be marking it with…
Kessler Researcher Awarded $408,000 by MS Society to Study Ways of Easing Fatigue
Ekaterina Dobryakova, PhD, was recently awarded a three-year grant worth $408,000 by the National Multiple Sclerosis Society to study…
PhRMA Report Looks at Decade of Progress in Treating MS and Other Chronic Diseases
A PhRMA report, titled “A Decade of Innovation in Chronic Diseases,” examined advances made in the treatment…
Montel Williams Joins KIND Board as an Advocate for Medical Marijuana
Montel Williams, a TV and radio talk show host and advocate for medical marijuana as a treatment for multiple sclerosis and…
MS Social Network in UK, Shift.ms, Testing an Online Therapy Tool to Help People Deal with Stresses of Disease
Shift.ms, the U.K. social network dedicated to people with multiple sclerosis (MS), is testing a new tool designed to…
Peripheral Neuropathy Reversed in Zebrafish After Treatment with 2 Drugs
A researcher has identified two drugs that may be used to reverse peripheral nerve damage, also referred to as peripheral neuropathy,…
Relapsing MS Treatment Showing Efficacy in Phase 2 Extension Study, Celgene Reports at ACTRIMS 2016
Celgene Corporation announced the results from an extension study of the RADIANCE Phase 2 clinical trial evaluating ozanimod in patients with relapsing…
MS Society Funds Research Using Zebrafish to Observe CD46 Protein and Its Role in Brain Inflammation
In an innovative research project funded by the National Multiple Sclerosis Society, Dr. Anne Astier from the University…
MS Incidence in UK Is Unrelated to Concentrations of Radon Gas, Researchers Find in Large-scale Study
Researchers at the University of Northampton’s Radon and Natural Radioactivity Research Group (RNRRG) developed a methodology to study whether radon gas,…
Progressive MS Trials May Need a ‘Tailored’ MRI Approach, Researcher Tells ACTRIMS 2016
Dr. Daniel S. Reich with Johns Hopkins University is giving an oral talk on “MRI as an…
Treadmill Exercise Benefits MS Patients, According to Study Presented at ACTRIMS Forum
Brian M. Sandroff from the Kessler Foundation and Robert W. Mot with the University of Illinois will present the…
ACTRIMS Session on MS Progression to Emphasize Continuing Treatment of Advancing Disease
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2016 starts today, Feb. 18, in New Orleans,…
US Moves Step Closer to National MS, Neurological Disease Registry with Senate Panel Vote
The U.S. Senate health committee recently passed the “Advancing Research for Neurological Diseases Act of 2015” (S. 849), sponsored…
MS Trial to Improve Physical Activity, Lower Fatigue via Telehealth Is Enrolling Participants
A new multiple sclerosis (MS) clinical trial being led by Case Western Reserve University investigators is now recruiting 215 individuals, across 10…
MS Relapse, Remission States Seen to Differ in Gene Expression Between Men and Women
A Spanish study showed that relapse and remission in multiple sclerosis (MS) states are regulated by small non-coding RNA (sncRNA)…
Multiple Sclerosis Co-Pay Relief Program Adds New Prescription Coverage
The Co-Pay Relief program offered through the Patient Advocate Foundation has added a new financial assistance fund to its collection of resources for patients…
Severe Demyelination in Non-MS Patient After TNF-α Blocker Treatment Detailed in Study
TNF-α blocking drugs, such as infliximab, surprised investigators when their use in people with multiple sclerosis (MS) actually triggered demyelination. In…
Long-term Multiple Sclerosis Study on Family and Environment May Help Predict Who Will Develop Disease
A research team at Brigham and Women’s Hospital (BWH) in Boston and the National Institute of Neurological Disorders…
MS Study Finds Lipid Antibodies Reflect Changes in Brain Volume and Lesions
Brigham and Women’s Hospital researchers reported that antibodies directed at lipids are associated with magnetic resonance imaging (MRI) measures of…